Profound Medical Corp (PROF) financials · rev $16.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Profound Medical Corp (PROF) rev $16.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $16.1M | $10.7M |
| Cost of Revenue | $4.71M | $3.64M |
| Gross Profit | $11.4M | $7.04M |
| Operating Income | -$41.3M | -$33.1M |
| Net Income | -$42.6M | -$27.8M |
| EPS (Diluted) | $1.41 | $1.12 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $77.5M | $70.2M |
| Current Assets | $76.1M | $69.1M |
| Cash & Equivalents | $59.7M | $54.9M |
| Inventory | $8.24M | $5.80M |
| PP&E | $698.0K | $425.0K |
| Total Liabilities | $11.0M | $9.81M |
| Current Liabilities | $6.08M | $6.57M |
| Short-term Debt | N/A | $1.74M |
| Long-term Debt | $4.50M | $2.92M |
| Total Debt | $4.50M† | $4.66M† |
| Shareholders' Equity | $66.4M | $60.4M |
| Retained Earnings | -$287.7M | -$245.2M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$38.2M | -$23.5M |
| CapEx | $176.0K | N/A |
| Investing Cash Flow | -$242.0K | N/A |
| Financing Cash Flow | $41.1M | $54.7M |
| Free Cash Flow | -$38.4M | N/A |
FAQ
What is PROF P/E and revenue?
Profound Medical Corp (PROF) rev $16.1M.
What is PROF revenue?
Profound Medical Corp last cached revenue is $16.1M (FY2025).
Is PROF profitable?
Profound Medical Corp last cached net income is -$42.6M (FY2025).
What are PROF total assets?
Profound Medical Corp last cached total assets are $77.5M (FY2025).
What is PROF free cash flow?
Profound Medical Corp last cached free cash flow is -$38.4M (FY2025).
Not investment advice. Cached statements, not a live tape.